Is there a role for routine p53 testing in colorectal cancer?

被引:13
作者
Hoff, PM [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
关键词
D O I
10.1200/JCO.2005.07.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:7395 / 7396
页数:2
相关论文
共 6 条
[1]   Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer:: A national cancer institute-national surgical adjuvant breast and bowel project collaborative study [J].
Allegra, CJ ;
Paik, S ;
Colangelo, LH ;
Parr, AL ;
Kirsch, I ;
Kim, G ;
Klein, P ;
Johnston, PG ;
Wolmark, N ;
Wieand, HS .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (02) :241-250
[2]   Disruption of p53 in human cancer cells alters the responses to therapeutic agents [J].
Bunz, F ;
Hwang, PM ;
Torrance, C ;
Waldman, T ;
Zhang, YG ;
Dillehay, L ;
Williams, J ;
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (03) :263-269
[3]  
DUKES C, 1930, BRIT J SURG, V12, P643
[4]   Prognostic value of p53 genetic changes in colorectal cancer [J].
Kressner, U ;
Inganäs, M ;
Byding, S ;
Blikstad, I ;
Påhlman, L ;
Glimelius, B ;
Lindmark, G .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) :593-599
[5]   CANCER - P53, GUARDIAN OF THE GENOME [J].
LANE, DP .
NATURE, 1992, 358 (6381) :15-16
[6]   The TP53 Colorectal Cancer International Collaborative Study on the prognostic and predictive significance of p53 mutation:: Influence of tumor site, type of mutation, and adjuvant treatment [J].
Russo, A ;
Bazan, V ;
Iacopetta, B ;
Kerr, D ;
Soussi, T ;
Gebbia, N .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) :7518-7528